Federal grant · project grant (b)
Starlight, the Next Generation X-ray Imaging Technology - Starlighttm, the Next Generation X-ray Imaging Technology Abstract Imagine Scientific Has Invented Starlight, an Ip-protected Monochromatic X-ray Source That Will Significantly Improve Medical Imaging. It Is a Long-awaited Engineering and Scientific Breakthrough, and the First Practical, Cost-effective, Clinical Source of Monochromatic X-rays for Diagnostic Imaging. in Its First Clinical Application, It Will Be Used in X-ray Mammography to Considerably Advance Screening and Diagnosis of Breast Cancer. Mammography Systems Using Starlight Will Offer (i) Superior Detection of Tumors for All Women, Including Those With Thick and Dense Breasts, (II) Significantly Lower Radiation Dose, (III) Elimination of Painful Breast Compression During Examinations, and (IV) Chemical Analysis of Tissue In-vivo. Breast Cancer Is the Most Common Cancer in Women, With Over 260,000 New Cases Diagnosed Each Year in the Us. 1 in 8 Women Will Develop Invasive Breast Cancer During Their Lifetime. 40%-50% of Women Have Dense Breasts (bi-rad Categories 3 and 4 - High Proportion of Glandular and Fibrous Tissue), Increasing Their Risk of Developing Cancer by 4 to 6 Times. the Detection Sensitivity Level for These Women Is 48%-64%, Compared to ~ 85% for Women With Less Glandular and Low Amounts of Fibrous Breast Tissue (bi-rad Categories 1 and 2). Starlight Addresses Unmet Women’s Health Needs Caused by the Performance Limitations of Current Mammography Systems. Mammography Systems Using Monochromatic X-rays Will Improve Detection Sensitivity for Early-stage Cancers in the ~45 Million Women Screened Each Year (us). Higher Sensitivity Will Reduce the Number of Missed Diagnoses of Cancer, While Higher Specificity Will Considerably Lower the Number of False Positive Cancer Detections and the Unnecessary Resulting Biopsies, Referrals for Adjuvant Ultrasound and Mri Scans, and Avoidable Costs and High Stress Levels for Affected Patients. in Addition to a More Conclusive Diagnosis, Women Screened With Starlight-based Mammography Systems Will Receive Considerably Lower Radiation Dose and Experience Breast Exams Without Undergoing Painful Breast Compression. Monochromatic Mammography’s Superior Performance Is Expected to Substantially Reduce Morbidity Associated With Misdiagnosed or Late-diagnosed Breast Cancer. Starlight Is the First Technology Capable of Producing Selectable, Monochromatic X-rays With the Required Intensity for Full-field Mammography and Can Be Integrated Into Conventional 2-D and 3-D Mammography Systems. the Cost to Manufacture a Starlight-based Mammography System Is Expected to Be Similar to Current Commercial Machines. Imagine Scientific Will Design, Fabricate and Build an Advanced Starlight Monochromatic X-ray Source With at Least 10 Times the Intensity of the Current Prototype, Enabling Exposure Times Between 1 and 7 Seconds. It Will Be Installed in a Commercial Mammography System, to Demonstrate Superior Image Quality and Lower Radiation Doses Compared to Current Mammography Systems.
Committed
$1.9 Million
Paid out
$1.8M
93%
Committed, not yet paid
$135.0K
7%
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.